Status:
COMPLETED
A Multi-Center Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
Lead Sponsor:
Mayo Clinic
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall goal is to improve shared decision-making (SDM) about treatment options and thereby enhance disease outcomes and health-related quality of life (HRQOL) for patients with rheumatoid arthrit...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age ≥ 18 years.
- Fulfillment of the ACR/EULAR 2010 classification criteria for RA \[9\].
- Moderate or high disease activity, according to CDAI ≥ 10, at the baseline visit.
- Intent to modify DMARD therapy (i.e., adding a DMARD, switching to a new DMARD, or changing DMARD dosage) by the patient and HCP.
- Exclusion criteria:
- Current or previous use of ArthritisPower™ by the patient.
- Lack of access to an ArthritisPower™ compatible device (e.g., smartphone, tablet, or computer)
- Inability or unwillingness to participate with using the ArthritisPower™ app for this study
Exclusion
Key Trial Info
Start Date :
October 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2023
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03773471
Start Date
October 20 2020
End Date
June 21 2023
Last Update
June 22 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Michigan Medicine - Rheumatology
Ann Arbor, Michigan, United States, 48109-5358
2
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905